\u003cp\u003e\u003cb\u003eHard-to-find insights from industry professionals on success strategies for developing the next generation of antiviral blockbuster drugs\u003c/b\u003e \u003cp\u003ePresented by industry professionals with a track record of discovering new drugs and treatments, \u003ci\u003eTrends in Antiviral Drug Development\u003c/i\u003e describes successful development efforts for antiviral compounds and therapies that have entered the market or are currently in clinical trials. Viruses are ordered by their target tissue, in line with contemporary drug development that focuses on tissue-targeted therapeutics. Other key trends in antiviral therapy, such as the effort to develop long-acting drugs, are described for each virus type, enabling readers to follow the current and future state in this core area of contemporary drug development. \u003cp\u003e\u003ci\u003eTrends in Antiviral Drug Development\u003c/i\u003e includes discussion on: \u003cul\u003e\u003cli\u003eNovel drugs against herpes viruses as well as the breakthrough drugs that cured HCV\u003c/li\u003e\u003cli\u003esiRNA therapeutics, a new antiviral modality, and the drug candidates that are progressing toward achieving an HBV cure\u003c/li\u003e\u003cli\u003eDrugs targeting viral entry, such as in HIV entry through attachment, co-receptor binding, and fusion\u003c/li\u003e\u003cli\u003eNovel therapeutics against tropical diseases such as dengue fever and monkey pox\u003c/li\u003e\u003c/ul\u003e \u003cp\u003e\u003ci\u003eTrends in Antiviral Drug Development\u003c/i\u003e is an essential read for medicinal chemists, pharmaceutical chemists, virologists, and all professionals seeking to understand new ideas and approaches to combat the ever-expanding universe of viral infections.
nl
en